Debra K. Liebert's Insider Trades & SAST Disclosures

Debra K. Liebert's most recent trade in Milestone Pharmaceuticals Inc was a trade of 16,793 Series A Common Warrants (right to buy) done . Disclosure was reported to the exchange on July 11, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2025 16,793 16,793 - - Series A Common Warrants (right to buy)
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2025 16,793 16,793 - - Series B Common Warrants (right to buy)
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2025 16,666 16,793 (0%) 0% - Common Shares
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 30,000 30,000 - - Stock Option (right to buy)
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Purchase of securities on an exchange or from another person at price $ 5.29 per share. 20 Oct 2022 10,000 10,000 (0%) 0% 5.3 52,900 Common Shares
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Purchase of securities on an exchange or from another person at price $ 5.26 per share. 20 Oct 2022 4,000 4,000 (0%) 0% 5.3 21,040 Common Shares
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Other type of transaction at price $ 0.00 per share. 14 Sep 2022 127 127 (0%) 0% 0 Common Shares
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2022 30,000 30,000 - - Stock Option (right to buy)
Milestone Pharmaceuticals Inc
Debra K. Liebert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades